抗病毒药物。
Antiviral agents.
作者信息
Reines E D, Gross P A
机构信息
Division of Infectious Diseases, Hackensack Medical Center, New Jersey.
出版信息
Med Clin North Am. 1988 May;72(3):691-715. doi: 10.1016/s0025-7125(16)30766-0.
Abstract
Potent effective antiviral drugs recently have been licensed for several viral diseases, ushering in a new era in the treatment of viral diseases. Several unique features in the process of a viral infection have been identified as target points for inhibition. The unique steps and the interfering compounds are the subject of this review.
摘要
强效有效的抗病毒药物最近已被批准用于多种病毒性疾病，开创了病毒性疾病治疗的新时代。病毒感染过程中的几个独特特征已被确定为抑制靶点。这些独特的步骤和干扰化合物是本综述的主题。
相似文献
1
Antiviral agents.抗病毒药物。
Med Clin North Am. 1988 May;72(3):691-715. doi: 10.1016/s0025-7125(16)30766-0.
2
Antiviral therapy. New drugs and their uses.
Postgrad Med. 1986 Jul;80(1):109-10, 113-4, 117-20. doi: 10.1080/00325481.1986.11699454.
3
Antiviral agents.抗病毒药物。
Mayo Clin Proc. 1987 Dec;62(12):1108-15. doi: 10.1016/s0025-6196(12)62505-1.
4
Drugs for non-HIV viral infections.用于非HIV病毒感染的药物。
Med Lett Drugs Ther. 1997 Aug 1;39(1006):69-76.
5
Drugs for non-HIV viral infections.用于非HIV病毒感染的药物。
Med Lett Drugs Ther. 1994 Apr 1;36(919):27-32.
6
Antiviral agents.
Obstet Gynecol Clin North Am. 1992 Sep;19(3):563-85.
7
Respiratory pharmacology. Antiviral agents.呼吸药理学。抗病毒药物。
Clin Chest Med. 1986 Sep;7(3):453-67.
8
Therapy of viral infections.病毒感染的治疗
Bull N Y Acad Med. 1982 Nov;58(8):711-20.
9
Antiviral agents for non-human immunodeficiency virus infections.用于非人类免疫缺陷病毒感染的抗病毒药物。
Mayo Clin Proc. 1999 Dec;74(12):1266-83. doi: 10.4065/74.12.1266.
10
Antiviral agents for the control of viral diseases.用于控制病毒疾病的抗病毒药物。
Bull World Health Organ. 1981;59(4):503-12.
引用本文的文献
1
Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety.聚乙二醇干扰素α-2a联合疗法用于在接受标准干扰素α-2b加利巴韦林治疗后复发或出现病毒突破的慢性丙型肝炎患者：一项疗效与安全性的初步研究
Dig Dis Sci. 2005 Apr;50(4):719-26. doi: 10.1007/s10620-005-2563-3.
2
A randomized, double-blind, placebo-controlled trial of interferon-alpha and amantadine versus interferon-alpha alone in the treatment of patients with chronic hepatitis C.
Dig Dis Sci. 2002 Jul;47(7):1655-6. doi: 10.1023/a:1015804227191.
3
Evaluation of free or liposome-encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis.游离或脂质体包裹的利巴韦林用于实验性诱导猫传染性腹膜炎抗病毒治疗的评估。
Res Vet Sci. 1993 Sep;55(2):162-72. doi: 10.1016/0034-5288(93)90076-r.
4
Toxicologic effects of ribavirin in cats.利巴韦林对猫的毒理学作用。
J Vet Pharmacol Ther. 1993 Sep;16(3):301-16. doi: 10.1111/j.1365-2885.1993.tb00177.x.
5
Adverse effects and drug interactions of clinical importance with antiviral drugs.抗病毒药物具有临床重要性的不良反应及药物相互作用。
Drug Saf. 1994 Apr;10(4):281-91. doi: 10.2165/00002018-199410040-00002.
6
Approaches to antiviral drug development.抗病毒药物研发方法。
Yale J Biol Med. 1989 Mar-Apr;62(2):215-25.
7
Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro.利巴韦林单独或与人α干扰素联合对猫传染性腹膜炎病毒体外复制的抑制作用。
Vet Microbiol. 1989 Jul;20(3):255-65. doi: 10.1016/0378-1135(89)90049-7.
8
Rapid viral diagnosis in perspective.透视快速病毒诊断
BMJ. 1990 Jun 2;300(6737):1413-8. doi: 10.1136/bmj.300.6737.1413.
本文引用的文献
1
Hypoxanthine-arabinoside pharmacokinetics after adenine arabinoside administration to a patient with renal failure.对一名肾衰竭患者给予阿糖腺苷后阿糖次黄嘌呤的药代动力学
Antimicrob Agents Chemother. 1980 Jul;18(1):212-4. doi: 10.1128/AAC.18.1.212.
2
Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure.
Am J Med. 1982 Jul 20;73(1A):202-4. doi: 10.1016/0002-9343(82)90091-2.
3
Acyclovir clinical pharmacology. An overview.
Am J Med. 1982 Jul 20;73(1A):193-6. doi: 10.1016/0002-9343(82)90089-4.
4
Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine.金刚烷胺、金刚乙胺和氯苯那敏对中枢神经系统副作用的双盲对照研究。
Antimicrob Agents Chemother. 1982 Jan;21(1):1-4. doi: 10.1128/AAC.21.1.1.
5
Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.阿糖腺苷治疗HBsAg阳性慢性肝病：一项对照研究。
Gastroenterology. 1981 May;80(5 pt 1):1016-22.
6
Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients.
Ann Intern Med. 1984 Apr;100(4):522-4. doi: 10.7326/0003-4819-100-4-522.
7
8
Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host.阿糖腺苷治疗免疫功能低下宿主的皮肤黏膜单纯疱疹病毒感染
J Infect Dis. 1984 Jan;149(1):1-8. doi: 10.1093/infdis/149.1.1.
9
Intralesional administration of large doses of human leukocyte interferon for the treatment of condylomata acuminata.
J Infect Dis. 1984 Oct;150(4):612-5. doi: 10.1093/infdis/150.4.612.
10
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol.用利巴韦林气雾剂治疗甲型H1N1流感病毒感染。
Antimicrob Agents Chemother. 1984 Aug;26(2):200-3. doi: 10.1128/AAC.26.2.200.
Zotero 插件